By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


True North Therapeutics  

951 Gateway Boulevard

South San Francisco  Califonia  94080  U.S.A.
Phone: 650-872-4700 Fax: n/a


Key Statistics

Ownership: Private

Web Site: True North Therapeutics


Company News
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009 5/19/2016 12:21:58 PM
True North Therapeutics Launches COMPASS Registry To Advance Development Of New Therapeutics For Patients With Cold Agglutinin Disease (And Other Autoimmune Hemolytic Anemias) 3/8/2016 9:28:39 AM
True North Therapeutics Receives Orphan Drug Designation In The European Union For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) 2/25/2016 9:48:39 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
True North Therapeutics To Present Clinical Data For Lead Product Candidate At J.P. Morgan Healthcare Conference 1/5/2016 11:32:27 AM
True North Therapeutics Presents Data In Patients With Cold Agglutinin Disease (CAD) Supporting Patient Profiles For TNT009 Phase Ib Study 12/7/2015 11:14:48 AM
With Almost $100 Million in Financing, Bay Area’s True North Therapeutics Jumps Into Immune System Clinical Trials 12/3/2015 6:01:01 AM
What You Need to Know About True North Therapeutics 12/2/2015 2:32:54 PM
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial 4/7/2015 5:36:23 AM
True North Therapeutics Appoints James Gilbert, M.D., As Chief Medical Officer 6/17/2014 1:15:52 PM